Mark Cuban Explains How PBMs and Wholesalers Rip Off Patients on Drug Prices

The Power of Pharmacy Benefit Managers (PBMs)

• 🎯 PBMs, often owned by large insurance companies, control drug benefits for millions of Americans, wielding significant power similar to Amazon's marketplace control.
• 💡 Unlike Amazon, which seeks lower prices, PBMs prefer higher drug prices because their revenue is tied to rebates and fees based on a drug's list price.
• ⚠️ Drug manufacturers pay substantial rebates and fees to PBMs to ensure their drugs are included on formularies, which determine what insurance covers.

Inflated List Prices and Wholesaler Markups

• 📈 The system incentivizes inflated list prices because PBMs and wholesalers make more money as prices rise.
• 🛒 Wholesalers purchase drugs at the same high list price and face zero competition due to uniform pricing and fees, further contributing to costs.
• 📉 Pharmacies often get reimbursed less than their acquisition cost for brand-name prescriptions, leading to independent pharmacies disappearing.

Patient Costs and the Broken System

• 💸 Patients, whether insured or uninsured, often pay the full list price for medications, especially if they haven't met their deductible.
• 💔 The current system fails to negotiate lower prices for patients, with rebates and fees flowing to PBMs instead of reducing patient out-of-pocket costs.
• 🤝 Contracts that lock in this broken system are renewed by self-insured employers, states, and the federal government, despite complaints about rising healthcare costs.

Proposed Solutions for Healthcare Reform

• 💰 Moving to net pricing (price after rebates and fees) could immediately halve patient out-of-pocket costs.
• 🏥 Key reforms include counting cash payments towards deductibles, basing patient costs on net price, separating formularies from PBMs, and eliminating specialty tiers.
• 🇺🇸 Implementing these changes would put patients, not PBMs, back at the center of American healthcare and address the high drug prices in the US.